Yilmaz, Y. Et Al. 2009. Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels. Hepatology , vol.49 , 697.

Yilmaz, Y., Ulukaya, E., & Dolar, E., (2009). Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels. Hepatology , vol.49, 697.

Yilmaz, YUSUF, Engin Ulukaya, And Enver Dolar. "Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels," Hepatology , vol.49, 697, 2009

Yilmaz, YUSUF Et Al. "Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels." Hepatology , vol.49, pp.697, 2009

Yilmaz, Y. Ulukaya, E. And Dolar, E. (2009) . "Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels." Hepatology , vol.49, p.697.

@article{article, author={YUSUF YILMAZ Et Al. }, title={Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels}, journal={Hepatology}, year=2009, pages={697} }